NCT00050063View on ClinicalTrials.gov

Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs

CompletedOBSERVATIONAL
Enrollment

78

Participants

Timeline

Start Date

Not specified

Study Completion Date

May 31, 2004

Conditions
HIV Infections
Interventions
BIOLOGICAL

Therapeutic vaccinations from A5058s

Participants will receive assigned interventions assigned in study A5058s.

Trial Locations (14)

10003

Beth Israel Med. Ctr., ACTU, New York

27514

Unc Aids Crs, Chapel Hill

46202

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis

Indiana Univ. School of Medicine, Wishard Memorial, Indianapolis

Methodist Hosp. of Indiana, Indianapolis

77555

Univ. of Texas Medical Branch, ACTU, Galveston

80262

University of Colorado Hospital CRS, Aurora

90502-2052

Harbor-UCLA Med. Ctr. CRS, Torrance

02114

Massachusetts General Hospital ACTG CRS, Boston

02118

Bmc Actg Crs, Boston

02215

Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston

Brigham and Women's Hosp. ACTG CRS, Boston

10016-6481

NY Univ. HIV/AIDS CRS, New York

44106-5083

Case CRS, Cleveland

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00050063 - Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs | Biotech Hunter | Biotech Hunter